lts and the results or statements of Takeda in this press release may not be indicative of, and are not an estimate, forecast, guarantee or projection of Takeda’s future results.

Takeda Medical Information
This press release contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, in different dosages, or in different strengths. Nothing contained herein should be considered a solicitation, promotion or advertisement for any prescription drugs including the ones under development.






_________________________________________________








References:


VONVENDI [von Willebrand factor (recombinant)] Prescribing Information; 2025.https:/www.shirecontent.com/PI/PDFs/VONVENDI_USA_ENG.pdf

What is von Willebrand disease? Centers for Disease Contro
=*=*=*=*=*=
当前为第16/17页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页